Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.49 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.44 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.44 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219127 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL21176005 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL29688566 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL4802159 | 1.00 | MBOAT4 (0.62) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL3268576 | 0.81 | MBOAT4 (0.53) | MBOAT4CYP19A1CDK5CDK5R1NR1I3 | |
| SCHEMBL1788661 | 0.80 | MBOAT4 (0.46) | MBOAT4CYP19A1GRIN1GRIN2BSHBG | |
| SCHEMBL2186022 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL1287860 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL1287861 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG | |
| SCHEMBL9512557 | 0.79 | CYP19A1 (0.55) | CYP19A1SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1467739-A4 | 17-HYDROXY-4-AZA-ANDROSTAN-3-ONES AS ANDROGEN RECEPTOR MODULATORS | MERCK & CO INC (US) | 2008-01-09 | — | — | EP | claimed |
| EP-1467739-A2 | 17-HYDROXY-4-AZA-ANDROSTAN-3-ONES AS ANDROGEN RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2004-10-20 | — | — | EP | claimed |
| EP-1463483-A1 | NEW COMPOSITION | Ponsus Pharma AB (SE) | 2004-10-06 | — | — | EP | claimed |
| WO-2003059293-A2 | 17-HYDROXY-4-AZA-ANDROSTAN-3-ONES AS ANDROGEN RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2003-07-24 | — | — | WO | claimed |
| WO-2003055454-A1 | NEW COMPOSITION | PONSUS PHARMA AB (SE) | 2003-07-10 | — | — | WO | claimed |
| EP-1322663-A1 | NOVEL POLYMORPHIC FORM OF 17-BETA-(N-TER.BUTYL CARBAMOYL)-4-AZA-5- G(A)-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT | Dr. Reddy's Laboratories Ltd. (IN) | 2003-07-02 | — | — | EP | claimed |
| WO-2002020553-A1 | NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT | DR. REDDY'S LABORATORIES LTD. (IN) | 2002-03-14 | — | — | WO | claimed |
| EP-0468012-B1 | 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | PHARMACIA SPA (IT) | 1995-09-20 | — | — | EP | claimed |
| EP-0649431-A4 | 17-AMINO SUBSTITUTED 4-AZASTEROID 5-G(A)-REDUCTASE INHIBITORS. | — | 1995-05-03 | — | — | EP | claimed |
| EP-0649431-A1 | 17-AMINO SUBSTITUTED 4-AZASTEROID 5$g(a)-REDUCTASE INHIBITORS | MERCK & CO. INC. (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1993023038-A1 | 17-AMINO SUBSTITUTED 4-AZASTEROID 5α-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | claimed |
| WO-1991012261-A1 | 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FARMITALIA CARLO ERBA S.R.L. (IT) | 1991-08-22 | — | — | WO | claimed |
| EP-0073026-B1 | 17,17-BIS(SUBSTITUTED THIO)-3-KETOANDROSTENES AND PHARMACEUTICAL COMPOSITIONS | E.R. Squibb & Sons, Inc. (US) | 1986-03-19 | — | — | EP | claimed |
| EP-0073026-A1 | 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions | E.R. Squibb & Sons, Inc. (US) | 1983-03-02 | — | — | EP | claimed |
| US-4361559-A | TOPICAL ADMINISTRATION FOR SKIN DISORDERS OF ASTHMA | E. R. SQUIBB & SONS, INC. (US) | 1982-11-30 | — | — | US | claimed |
| CN-111356449-B | Dutasteride solid dispersion, preparation method thereof and pharmaceutical composition containing same | 韩国普莱姆制药株式会社 | 2022-12-02 | — | — | CN | disclosed |
| CN-107206010-B | C-19 steroids to inhibit neovascularization | 库拉迪斯有限公司 | 2021-12-21 | — | — | CN | disclosed |
| EP-0100566-A1 | Novel 19-thio-androstane derivatives | AKZO N.V. (NL) | 1984-02-15 | — | — | EP | disclosed |
| EP-0073026-A1 | 17,17-Bis(substituted thio)-3-ketoandrostenes and pharmaceutical compositions | E.R. Squibb & Sons, Inc. (US) | 1983-03-02 | — | — | EP | disclosed |
| US-4361559-A | TOPICAL ADMINISTRATION FOR SKIN DISORDERS OF ASTHMA | E. R. SQUIBB & SONS, INC. (US) | 1982-11-30 | — | — | US | disclosed |